Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

US Patent 8716486 · Granted May 6, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohex2024
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial di2023
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial di2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treatin2023
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoqu2023
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treatin2023
Process for the production of alpha-tocotrienol and derivatives2022
Process for the production of alpha-tocotrienol and derivatives2022
Process for the production of alpha-tocotrienol and derivatives2022
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treati2021
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoqu2021
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial di2021